Professor Seungpyo Hong continues to advance technology to track circulating tumor cells, which could lead to a more effective, easier way to monitor cancer progression.
 
	 
	Professor Seungpyo Hong continues to advance technology to track circulating tumor cells, which could lead to a more effective, easier way to monitor cancer progression.
 
	Assistant Professor Quanyin Hu has developed a new method for targeting tumors with cancer drugs by exploiting the clotting propensity of blood platelets.
 
	A recent study by Assistant Professor Quanyin Hu points toward a potential new approach for pushing the limits of immunotherapy, opening a door to more effective treatment of inoperable tumors and metastatic cancer.
 
	School of Pharmacy Assistant Professor Quanyin Hu and collaborators publish preclinical results on a new approach to prevent glioblastoma recurrence.